Morgan Stanley’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.9M | Sell |
511,380
-788,602
| -61% | -$38.4M | ﹤0.01% | 2588 |
|
|
2025
Q1 | $44.2M | Buy |
1,299,982
+804,980
| +163% | +$27.4M | ﹤0.01% | 1923 |
|
|
2024
Q4 | $19.5M | Sell |
495,002
-137,001
| -22% | -$5.39M | ﹤0.01% | 2772 |
|
|
2024
Q3 | $29.7M | Buy |
632,003
+34,324
| +6% | +$1.61M | ﹤0.01% | 2390 |
|
|
2024
Q2 | $32.3M | Sell |
597,679
-488,245
| -45% | -$26.4M | ﹤0.01% | 2162 |
|
|
2024
Q1 | $74M | Buy |
1,085,924
+259,770
| +31% | +$17.7M | 0.01% | 1405 |
|
|
2023
Q4 | $51.7M | Buy |
826,154
+474,719
| +135% | +$29.7M | ﹤0.01% | 2415 |
|
|
2023
Q3 | $16M | Sell |
351,435
-39,405
| -10% | -$1.79M | ﹤0.01% | 2688 |
|
|
2023
Q2 | $21.9M | Sell |
390,840
-79,686
| -17% | -$4.47M | ﹤0.01% | 2386 |
|
|
2023
Q1 | $21.3M | Sell |
470,526
-37,267
| -7% | -$1.69M | ﹤0.01% | 2353 |
|
|
2022
Q4 | $20.6M | Sell |
507,793
-78,051
| -13% | -$3.17M | ﹤0.01% | 2314 |
|
|
2022
Q3 | $38.3M | Buy |
585,844
+18,386
| +3% | +$1.2M | 0.01% | 1535 |
|
|
2022
Q2 | $34.5M | Buy |
567,458
+50,070
| +10% | +$3.04M | ﹤0.01% | 1705 |
|
|
2022
Q1 | $32.5M | Sell |
517,388
-26,122
| -5% | -$1.64M | ﹤0.01% | 1638 |
|
|
2021
Q4 | $41.2M | Sell |
543,510
-36,511
| -6% | -$2.77M | 0.01% | 1489 |
|
|
2021
Q3 | $64.9M | Buy |
580,021
+60,256
| +12% | +$6.74M | 0.01% | 1122 |
|
|
2021
Q2 | $84.1M | Sell |
519,765
-347,503
| -40% | -$56.3M | 0.01% | 956 |
|
|
2021
Q1 | $106M | Buy |
867,268
+135,841
| +19% | +$16.6M | 0.02% | 739 |
|
|
2020
Q4 | $112M | Buy |
731,427
+227,927
| +45% | +$34.9M | 0.02% | 670 |
|
|
2020
Q3 | $42.1M | Sell |
503,500
-57,813
| -10% | -$4.84M | 0.01% | 995 |
|
|
2020
Q2 | $41.3M | Sell |
561,313
-290,206
| -34% | -$21.3M | 0.01% | 936 |
|
|
2020
Q1 | $36.1M | Buy |
851,519
+596,255
| +234% | +$25.3M | 0.01% | 899 |
|
|
2019
Q4 | $15.5M | Sell |
255,264
-3,477
| -1% | -$212K | ﹤0.01% | 1902 |
|
|
2019
Q3 | $10.6M | Sell |
258,741
-26,243
| -9% | -$1.08M | ﹤0.01% | 2060 |
|
|
2019
Q2 | $13.4M | Buy |
284,984
+16,361
| +6% | +$771K | ﹤0.01% | 1849 |
|
|
2019
Q1 | $9.6M | Buy |
268,623
+75,437
| +39% | +$2.69M | ﹤0.01% | 2078 |
|
|
2018
Q4 | $5.52M | Sell |
193,186
-39,354
| -17% | -$1.12M | ﹤0.01% | 2788 |
|
|
2018
Q3 | $10.3M | Buy |
232,540
+36,098
| +18% | +$1.6M | ﹤0.01% | 2391 |
|
|
2018
Q2 | $11.5M | Buy |
196,442
+99,822
| +103% | +$5.87M | ﹤0.01% | 2208 |
|
|
2018
Q1 | $4.42M | Buy |
96,620
+7,814
| +9% | +$357K | ﹤0.01% | 3156 |
|
|
2017
Q4 | $2.09M | Buy |
88,806
+50,036
| +129% | +$1.17M | ﹤0.01% | 4000 |
|
|
2017
Q3 | $693K | Sell |
38,770
-708,952
| -95% | -$12.7M | ﹤0.01% | 4674 |
|
|
2017
Q2 | $12M | Buy |
747,722
+727,196
| +3,543% | +$11.7M | ﹤0.01% | 1999 |
|
|
2017
Q1 | $447K | Buy |
20,526
+16,710
| +438% | +$364K | ﹤0.01% | 4907 |
|
|
2016
Q4 | $77K | Buy |
+3,816
| New | +$77K | ﹤0.01% | 5646 |
|